Stocks Market
Vicenne Beats 2025 Business Plan with 58% Profit Surge
In 2025 Vicenne delivered a 58% jump in net profit, surpassing its original business plan. Revenue rose 30% to 1,084 million Dirhams, driven by strong performance in imaging and laboratory equipment, while EBITDA grew 50% to 264.2 million Dirhams. The company declared a dividend of 8.44 Dirhams per share and outlined ambitious 2030 targets of 1,814 million Dirhams in revenue and 440 million Dirhams in EBITDA, backed by significant 2026 investments.
Listen to this article
Unlock audio versions of premium articles and more with a Pro subscription.
Annual Performance Highlights
The 2025 fiscal year saw Vicenne post a consolidated revenue of 1,084 million Dirhams, a 30% year‑on‑year increase, driven by robust growth across all business segments. The imaging and laboratory equipment divisions surged 113% and 59% respectively, contributing to a 50% rise in EBITDA to 264.2 million Dirhams, reflecting efficient cost management. Net profit climbed 58% to 144 million Dirhams, exceeding the original business plan targets.
Looking ahead, Vicenne aims to reach 1,814 million Dirhams in revenue and 440 million Dirhams in EBITDA by 2030 (on a constant scope basis, excluding planned investments). Significant capital expenditures are slated for 2026 to fund diversification and expansion initiatives.
Key articles and investment highlights are listed below:
- Vicenne: 30% revenue jump, crosses 1 billion Dirhams
- Mabiotech subsidiary receives international recognition
- Record‑breaking IPO
- Revenue up 25% in the first nine months of 2025